-
-
Humane Society (May 5, 2023) Disappointing National Academies study largely fails animals and people
The National Academies of Science, Engineering and Medicine published a report yesterday analyzing the use of primates in experiments funded by the National Institutes of Health and examining “opportunities for new approach methodologies to complement or reduce reliance on NIH-supported research with nonhuman primates.” The 250-page report, written by a committee largely composed of people involved in the primate research industry, takes a short-sighted view, calling for the U.S. to expand primate breeding and increase primate experiments. The Humane Society of the United States and Humane Society Legislative Fund are urging the NIH to reject the conclusions in the report calling for increased breeding of primates and instead increase investment in development and validation of non-animal methods.
AAMC (May 4, 2023) 5 medical advances that will change patient care
#5 …Vagina on a chip
Pharmaphorum (May 4, 2023) Roche launches human model systems institute The Institute of Human Biology (IHB) aims to bring together scientists across academia and industry to work on human model systems that can be used to predict which drug candidates are safe and effective, and potentially reduce the need for animal testing.
GenomeWeb (May 3, 2023) Wyss Program Aims to Fast Track New Testing Technologies to Market
An analysis of 37 early-phase immunotherapy studies has provided more evidence that circulating tumor DNA (ctDNA) could serve as an alternative endpoint to radiographic response in cancer clinical trials.
Charlotte Inno (May 1, 2023) Cornelius-based startup Phase lands NC Biotech funding to bring 3D concepts to market
Phase Inc. makes 3D-printing medical devices for microfluidics, a science based on systems that manipulate small amounts of fluid, with channels typically having the same diameter as a strand of hair. The startup also develops organ-on-a-chip devices, a technology that allows researchers to mimic the function of tissues and organs. The company landed a small business research loan from NC Biotech, a life science economic development organization. That NC Biotech program provides investments of $100,000 to $250,000 to support early-stage life science companies across the state. Phase received the maximum loan amount, bringing the company’s total non dilutive funding to $2.3 million, a spokesperson at the startup confirmed to CBJ.
Forbes (April 28, 2023) Forget AI; Organoid Intelligence May Soon Power Our Computers
While the world has been captivated by recent advances in artificial intelligence, researchers at Johns Hopkins University have identified a new form of intelligence: organoid intelligence. A future where computers are powered by lab-grown brain cells may be closer than we could ever have imagined.
-
- You must be logged in to reply to this topic.